Location: Home
  • search
  • go
  • Relate News
  • 7/22/2022Novaremed Enters License Pact with NeuroFront for Non-opioid Neuropath...
  • 7/21/2022WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...
  • 7/21/2022A Practical Review of the New Supporting Regulations of China's Anti-M...
  • 7/21/2022A Practical Review of the Amended Anti-Monopoly Law of China: Highligh...
  • 7/21/2022Draft "Regulation on Prohibition for Abuse of IP Rights to Exclude or ...
  • 7/20/2022China's Prospective Payment System: 3 Ways to Prepare
  • 7/20/2022Official Data: Chinese Pharma Growth Slows in H1/2022
  • 7/19/2022WuXi STA Opens a New Large Scale Continuous Manufacturing Plant
  • 7/19/2022WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...
  • 7/19/2022CDE Solicits Comments on the Draft Guidelines for Clinical Development...
  • 7/19/2022NHSA Issues New Notice to Further Strengthen Regulation of Medical Ser...
  • 7/18/2022Pharmanovia Expands Its Footprint in China With The Acquisition of Roc...
  • 7/18/2022NHC's 2021 Annual Health Sector Development Report (Full Summary)
  • 7/18/2022How China's Big Pharma Bet Could Change Intellectual Property Game
  • 7/15/2022China's Community Health Centers Are Losing Public Appeal
  • 7/15/2022Chinese Leaders Pledge to Advance Reform and Reduce Public Healthca...
  • 7/15/2022Recent Official and Executive Moves
  • 7/14/2022CStone Considers Sale Amid Mounting Challenges: Bloomberg
  • 7/14/2022China's Latest Round of Volume-Based Procurement of Drugs Further Redu...
  • 7/14/2022Chinese Biopharma In-licensing Deals in H1/2022 (Pharmcube)
  • 7/14/2022China's Budding Drug Innovation Shows Signs of Life Despite Biotech Wi...
  • 7/13/2022Chinese Drugmakers Set Sights on Emerging Markets (PharmaDJ)
  • 7/13/2022Chinese Biopharma Out-licensing Deals in H1/2022 (Pharmcube)
  • 7/12/2022AstraZeneca, Pfizer, Novartis and More Lose Out in China's Latest Roun...
  • 7/12/2022Youtube Video: Layoff Triggered in China's Pharma as Beijing Continues...
  • 7/12/2022JPO Publicizes 7th VBP Tender Outcome, Which Slashes Average Prices by...
  • 7/11/2022NMPA Announces OTC Switch of Potassium Glucosamine Sulfate Tablets
  • 7/11/2022Tasly Pharma and Mauna Kea Tech Announce JV and Licensing Pact
  • 7/8/2022Chinese Government Issues New Document to Secure Urban/Rural Resident ...
  • 7/8/2022Sinopharm Explores $1 Billion Deal for BBI Life Sciences
  • Page:69/362 Total number of articles:10841: [First][<<] [67] [68] [69] [70] [71] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group